Comparison of alternative evidence summary and presentation formats in clinical guideline development: a mixed-method study. by Opiyo, Newton et al.
Opiyo, N; Shepperd, S; Musila, N; Allen, E; Nyamai, R; Fretheim,
A; English, M (2013) Comparison of alternative evidence summary
and presentation formats in clinical guideline development: a mixed-
method study. PLoS One, 8 (1). e55067. ISSN 1932-6203 DOI:
10.1371/journal.pone.0055067
Downloaded from: http://researchonline.lshtm.ac.uk/1175546/
DOI: 10.1371/journal.pone.0055067
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
May 2010 – KEMRI/Wellcome Trust Research Programme, Child and Newborn Health Group, Nairobi 
 
1 
 
1 
 
 
 
 
Clinical need 
 
Kangaroo mother care (KMC), defined as continuous skin to skin between a mother and her 
newborn allowing frequent and exclusive breastfeeding, has been proposed as an alternative to 
conventional care (incubators, cots, etc) for low birth weight (LBW, less than 2500 g) babies. 
The evidence for the effectiveness and safety of KMC versus conventional care in LBW infants 
is considered in this summary.  
 
Clinical questions, Quality of evidence‡ and Key findings  
• Population: Low birth weight infants, less than 2500 g 
• Comparisons: Kangaroo mother care versus conventional care 
• Outcomes: Neonatal mortality, morbidity, breastfeeding status, costs and length of 
hospital stay 
 
Evidence summary: Kangaroo mother care for low birth weight infants  
 
1. What is the evidence that KMC reduces the risk of mortality in LBW infants? 
 
 
Key findings 
• Low quality evidence suggests that KMC does not reduce the risk of death in 
stabilized LBW infants 
 
• Low quality evidence suggests that KMC may reduce the risk of death in LBW 
infants if initiated very early in life before stabilization 
2. What is the evidence that KMC reduces morbidity in LBW infants? 
 
Key findings 
• Low quality evidence suggests that KMC reduces the risk of morbidity (mild / 
illnesses, nosocomial infections) in LBW infants. 
 
3. What is the evidence that KMC improves breastfeeding outcomes in LBW infants? 
 
 
Key findings 
• Low quality evidence suggests that KMC increases the likelihood of exclusive 
breastfeeding at discharge in LBW infants 
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‡ Quality of evidence is categorized as ‘high’, ‘moderate’, ‘low’ or ‘very low’. 
• HIGH: Further research is very unlikely to change our confidence in the estimate of 
effect. 
• MODERATE: Further research is likely to have an important impact on our confidence in 
the estimate of effect and may change the estimate. 
• LOW: Further research is very likely to have an important impact on our confidence in 
the estimate of effect and is likely to change the estimate. 
• VERY LOW: We are very uncertain about the estimate. 
 
• Moderate quality evidence suggests that KMC increases the likelihood of exclusive 
breastfeeding at 41 weeks corrected age in LBW infants 
 
• Very low quality evidence suggests that KMC may improve the chances of 
exclusive breastfeeding of LBW infants at the age of six months post birth 
 
4. What is the evidence that KMC reduces the length of hospital stay of LBW infants? 
 
Key findings 
• Low quality evidence suggests that LBW babies on KMC stay hospitalized for a 
shorter duration compared to those on conventional care 
 
5. What is the evidence for the cost-benefit of KMC compared to standard neonatal 
care? 
 
 
Key findings 
• Very low quality evidence suggests that the cost of care for babies on KMC is 
lower than the costs of standard care 
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Quality of Evidence and Summary of Findings 
Question 1:  What is the evidence that KMC reduces the mortality risk in LBW infants? 
 
Intervention: Kangaroo mother care 
Comparison: Conventional care 
Bibliography: Worku et al3; Charpak et al4; Sloan et al5; Cattaneo et al5; Suman et al9 
 
Quality assessment Summary of findings 
Importance 
 
Effect size 
(95% CI) 
Quality 
(GRADE) No of studies 
No of 
infants 
Design Limitations Inconsistency Indirectness Imprecision 
Mortality before stabilization (follow-up 4 to 6 days) 
1 123 randomised 
controlled 
trial 
serious† no serious 
inconsistency 
no serious 
indirectness 
serious‡ 
RR 0.57  
(0.33 to 1.0) 
⊕⊕ٚٚ 
LOW 
CRITICAL 
Mortality after stabilization (follow-up 1 to 7 weeks) 
4 1512 randomised 
controlled 
trials 
serious†† no serious 
inconsistency 
no serious 
indirectness 
no serious 
imprecision 
RR 0.70 
(0.41 to 
1.21) 
⊕⊕⊕ٚ 
MODERATE
CRITICAL 
† - significant number of recruited infants not randomised, blinding of investigators / data collectors unclear; ‡ small sample size, 
wide 95% confidence interval; †† blinding of investigators / data collectors unclear, potential for reporting bias (selective reporting of 
outcomes) 
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Question 2:  What is the evidence that KMC reduces morbidity in LBW infants? 
 
Intervention: Kangaroo mother care 
Comparison: Conventional care 
Bibliography: Charpak et al4 Sloan et al5; Cattaneo et al6; Charpak et al7 
 
Quality assessment Summary of findings 
Importance 
 
Effect size 
(95% CI) 
Quality 
(GRADE) No of studies 
No of 
infants 
Design Limitations Inconsistency Indirectness Imprecision 
Morbidity (risk of severe illness at discharge) 
1 285 randomised 
controlled 
trial 
serious† no serious 
inconsistency 
no serious 
indirectness 
serious‡ RR 0.51 
(0.28 to 
0.94) 
⊕⊕ٚٚ 
LOW 
CRITICAL 
Morbidity (risk of infectious episodes at 40 to 41 weeks corrected age; follow-up 3 to 10 weeks) 
1 746 randomised 
controlled 
trial 
serious¶ no serious 
inconsistency 
no serious 
indirectness 
serious‡ RR 1.06 
(0.72 to 
1.54) 
⊕⊕ٚٚ 
LOW 
CRITICAL 
Morbidity (risk of nosocomial infections at 40 to 41 weeks corrected age; follow-up 3 to 10 weeks) 
1 285 randomised 
controlled 
trial 
serious¶ no serious 
inconsistency 
no serious 
indirectness 
serious‡ RR 0.47  
(0.30 to 
0.73) 
⊕⊕ٚٚ 
LOW 
CRITICAL 
Morbidity (risk of severe illness at 6 months (follow-up 0-6 months) 
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1 275 randomised 
controlled 
trial 
serious¶ no serious 
inconsistency 
no serious 
indirectness 
serious‡ RR 0.90  
(0.30 to 
0.66) 
⊕⊕ٚٚ 
LOW 
CRITICAL 
Morbidity (risk of severe illness at 1 year corrected age; follow-up 0 to 12 months) 
1 285 randomised 
controlled 
trial 
serious†† no serious 
inconsistency 
no serious 
indirectness 
serious‡ RR 0.95 
(0.06 to 
15.09) 
⊕⊕ٚٚ 
LOW 
CRITICAL 
† - blinding of intervention to both investigators and data collectors unclear; ‡ - few number of events; ¶ - unclear concealment of 
intervention allocation, unblinded outcome assessment; †† - significant loss to follow-up 
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Question 3:  What is the evidence that KMC improves breastfeeding outcomes in LBW infants? 
 
Intervention: Kangaroo mother care 
Comparison: Conventional care 
Bibliography: Cattaneo et al6; Hake-Brooks et al11; Rojas et al12; Boo et al13   
Quality assessment Summary of findings 
Importance 
 
Effect size 
(95% CI) 
Quality 
(GRADE) No of studies 
No of 
infants 
Design Limitations Inconsistency Indirectness Imprecision 
Breastfeeding (exclusively at discharge; follow-up 0 to 30 days) 
4 537 randomised 
controlled 
trial 
serious† no serious 
inconsistency 
serious‡  no serious 
imprecision RR 1.33 (1.17 to 1.5) 
⊕⊕ٚٚ 
LOW 
IMPORTANT 
Breastfeeding (exclusively at 40 to 41 weeks corrected age; follow-up 0 to 10 weeks) 
1 746 randomised 
controlled 
trial 
serious† no serious 
inconsistency 
no serious 
indirectness 
no serious 
imprecision 
RR 1.02 
(0.87 to 
1.21) 
⊕⊕⊕ٚ 
MODERATE
IMPORTANT 
Breastfeeding (exclusively at 6 months of age; follow-up mean 6 months) 
1 66 randomised 
controlled 
trial 
serious¶ no serious 
inconsistency 
serious‡ serious†† RR 2.51  
(0.11 to 
59.53) 
⊕ٚٚٚ 
VERY LOW 
IMPORTANT 
Breastfeeding (follow-up 0 to 12 months) 
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2 759 randomised 
controlled 
trial 
serious† no serious 
inconsistency 
serious‡  serious†† RR 0.92  
(0.69 to 
1.23) 
⊕ٚٚٚ 
VERY LOW 
IMPORTANT 
† - unclear concealment of allocation of interventions / blinding of outcome assessment; ‡ - one of the included studies conducted in 
a high income setting with a lactation consultant; ¶ - unclear concealment of allocation of interventions; †† - small number of events 
(<300) 
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Question 4:  What is the evidence that KMC reduces the length of hospital stay of LBW infants? 
 
Intervention: Kangaroo mother care 
Comparison: Conventional care 
Bibliography: Kadam et al8; Gathwala et al10; Boo et al13 
 
Quality assessment Summary of findings 
Importance 
 
Effect size 
(95% CI) 
Quality 
(GRADE) No of studies 
No of 
infants 
Design Limitations Inconsistency Indirectness Imprecision 
Length of hospital stay (follow-up 0 to 40 days) 
1 126 randomised 
controlled 
trial 
serious† no serious 
inconsistency 
no serious 
indirectness  
serious‡  13.5 days 
(KMC) 
versus 22.5 
days (CMC) 
⊕⊕ٚٚ 
LOW 
IMPORTANT 
Length of hospital stay (follow-up 0 to 2 months) 
2 199 randomised 
controlled 
trial 
serious† serious¶  no serious 
indirectness 
serious‡  KMC = 
shorter 
duration of 
hospital 
stay†† 
⊕ٚٚٚ 
VERY LOW 
IMPORTANT 
† - unclear concealment of allocation of interventions / blinding of outcome assessment /selective reporting of outcomes; ‡ - small 
number of enrolled participants; CMC - conventional method of care ¶ - age at randomisation into KMC group inconsistent across 
included studies; †† - Gathwala et al; (KMC, 3.56 days versus CMC, 6.8 days), Kadam et al (KMC, 8.5 days versus CMC, 9.3 days)  
 
May 2010 – KEMRI/Wellcome Trust Research Programme, Child and Newborn Health Group, Nairobi 
 
9 
 
9 
Question 4:  What is the evidence that KMC reduces the length of hospital stay of LBW infants? 
 
Intervention: Kangaroo mother care 
Comparison: Conventional care 
Bibliography: Sloan et al5; Cattaneo et al6 
 
Quality assessment Summary of findings 
Importance 
 
Effect size 
(95% CI) 
Quality 
(GRADE) No of studies 
No of 
infants 
Design Limitations Inconsistency Indirectness Imprecision 
Cost of care (follow-up 0 to 6 months) 
2 560 observational 
studies 
very 
serious† 
no serious 
inconsistency 
serious‡  no serious 
imprecision  
KMC = 
Lower costs 
of care¶ 
⊕ٚٚٚ 
VERY LOW 
IMPORTANT 
† - potential for selection / investigator bias in recruitment of participants / measurement of outcomes; ‡ - items costed unclear; ¶ - 
Sloan et al (KMC, US $101 versus CMC, US $130), Cattaneo et al (KMC, US $7,501 versus CMC, US $9,876)  
 
 
May 2010 – KEMRI/Wellcome Trust Research Programme, Child and Newborn Health Group, Nairobi 
 
10 
 
10 
Characteristics of the evidence  
This evidence summary is based on a comprehensive search and critical appraisal (for 
methodological rigor and clinical practice applicability) of best currently available literature. The 
evidence in this summary comes from: 
• One Cochrane review of randomised controlled trials (RCTs) (N=1,362 infants, 3 
studies)1  
• One overview of 2 systematic reviews and 7 RCTs2 
• Ten RCTs (N=2,086 infants)3-12  
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